Vimian Group AB (publ) Stock: price and insider trades · Sweden

Vimian Group AB (publ) belongs to the Health Care sector. Filings by its managers are published through Finansinspektionen. 22 insiders have disclosed 64 filings since 18 October 2025.

On the market, 15 insiders bought (33 purchases totalling €46.6M) while 6 insiders sold (6 sales totalling €973k). Netting one side against the other leaves €45.6M of net buying. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Among those who bought: 6 chief executives, 5 board members and 1 senior executive. Gabriel Fitzgerald filed the largest purchase, €13.0M, on 26 August 2026, which represents 0.79% of the company's market value.

Compared with its exchange (886 companies, median 7 filings), a count of 64 filings is above the norm. Our records for Vimian Group AB (publ) go back to 2025, with 40 purchases and 8 sales on the open market in total.

Within a 30-day window, 22 purchases overlapped with buying by a second insider. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The most recent open-market purchase was published on 21 September 2026, 26 days ago. Typically, a trade is published a median of 3 days after it takes place. The regulation allows three business days to notify a trade (MAR article 19).

Other companies in the same sector with recent insider buying flagged by our signals: MAIA Biotechnology, Inc. and Cooper Companies, Inc. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.